rs61910712
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001365276.2(TNXB):āc.3380A>Gā(p.Lys1127Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00316 in 1,608,148 control chromosomes in the GnomAD database, including 137 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Consequence
NM_001365276.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TNXB | NM_001365276.2 | c.3380A>G | p.Lys1127Arg | missense_variant | 8/44 | ENST00000644971.2 | NP_001352205.1 | |
TNXB | NM_019105.8 | c.3380A>G | p.Lys1127Arg | missense_variant | 8/44 | NP_061978.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TNXB | ENST00000644971.2 | c.3380A>G | p.Lys1127Arg | missense_variant | 8/44 | NM_001365276.2 | ENSP00000496448 | |||
TNXB | ENST00000647633.1 | c.4121A>G | p.Lys1374Arg | missense_variant | 9/45 | ENSP00000497649 | P1 | |||
TNXB | ENST00000375244.7 | c.3380A>G | p.Lys1127Arg | missense_variant | 8/44 | 5 | ENSP00000364393 |
Frequencies
GnomAD3 genomes AF: 0.0165 AC: 2510AN: 152028Hom.: 66 Cov.: 32
GnomAD3 exomes AF: 0.00399 AC: 974AN: 244128Hom.: 30 AF XY: 0.00326 AC XY: 436AN XY: 133598
GnomAD4 exome AF: 0.00176 AC: 2568AN: 1456002Hom.: 72 Cov.: 31 AF XY: 0.00152 AC XY: 1102AN XY: 724026
GnomAD4 genome AF: 0.0165 AC: 2510AN: 152146Hom.: 65 Cov.: 32 AF XY: 0.0162 AC XY: 1203AN XY: 74388
ClinVar
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Ehlers-Danlos syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, The Hospital for Sick Children | Mar 15, 2022 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 09, 2018 | - - |
Cardiovascular phenotype Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 23, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at